HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vishnu Muthuraj Kumarasamy Selected Research

NSC311153

7/2017Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vishnu Muthuraj Kumarasamy Research Topics

Disease

3Thyroid Neoplasms (Thyroid Cancer)
01/2020 - 08/2015
2Papillary Thyroid Cancer
07/2017 - 08/2015
1Neoplasms (Cancer)
07/2017

Drug/Important Bio-Agent (IBA)

2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
07/2017 - 08/2015
1salinomycinIBA
01/2020
1NSC311153IBA
07/2017
1ellipticineIBA
07/2017
1BerberineIBA
08/2015
1AlkaloidsIBA
08/2015